Literature DB >> 7914304

Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome.

N Schupf1, D Kapell, J H Lee, R Ottman, R Mayeux.   

Abstract

Most adults with Down's syndrome (DS) develop neuropathology characteristic of Alzheimer's disease (AD) by the age of 40. Most of the non-dysjunction events in DS are of maternal origin. We postulated therefore that a shared genetic susceptibility to DS and AD would be associated with an increased frequency of AD among mothers, but not fathers, of individuals with DS. We further hypothesised that the shared susceptibility could involve an accelerated ageing process, leading to the birth of a child with DS to a relatively young mother and to an increased risk of dementia in the mother and her relatives. Families of 96 adults with DS and of 80 adults with other forms of mental retardation were ascertained through the New York State Developmental Disabilities services network. A semi-structured interview was used to obtain information on the presence or absence of non-stroke-related dementia and other disorders in parents. There was an increase in risk of dementia among mothers of DS probands compared with control mothers (risk ratio 2.6 [95% CI 0.9-7.3]). The risk of dementia among mothers who were 35 or younger when their DS children were born was 5 times that of control mothers (4.9 [1.6-15.4]). There was no increase in risk of dementia among mothers who were older (> 35 years) at the proband's birth (0.8 [0.2-3.4]). There was no difference in risk of dementia between fathers of DS cases and fathers of controls (1.2 [0.4-3.9]) and no discernible influence of age on this risk. Familial aggregation of dementia among mothers of adults with DS supports the hypothesis of a shared genetic susceptibility to DS and AD.

Entities:  

Mesh:

Year:  1994        PMID: 7914304     DOI: 10.1016/s0140-6736(94)91398-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  Prospective assessment of fetal-maternal cell transfer in miscarriage and pregnancy termination.

Authors:  S E Peterson; J L Nelson; K A Guthrie; V K Gadi; T M Aydelotte; D J Oyer; S W Prager; H S Gammill
Journal:  Hum Reprod       Date:  2012-06-29       Impact factor: 6.918

2.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

Review 3.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

4.  Alzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motors.

Authors:  Sergiy I Borysov; Antoneta Granic; Jaya Padmanabhan; Claire E Walczak; Huntington Potter
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

5.  High incidence of Down's syndrome in infants of diabetic mothers.

Authors:  H Narchi; N Kulaylat
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

6.  Down's syndrome and the links with Alzheimer's disease.

Authors:  A J Holland; C Oliver
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

Review 7.  Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

Authors:  Huntington Potter; Antoneta Granic; Julbert Caneus
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

8.  One-carbon metabolism and Alzheimer's disease: focus on epigenetics.

Authors:  Fabio Coppedè
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

9.  Potential interaction between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF transcription factor in Down syndrome-related Alzheimer disease.

Authors:  Disha Banerjee; Krishnadas Nandagopal
Journal:  Cell Mol Neurobiol       Date:  2007-09-28       Impact factor: 5.046

10.  Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP.

Authors:  Antoneta Granic; Jaya Padmanabhan; Michelle Norden; Huntington Potter
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.